We are live on
!
Find out more
EA
Evanston Advisors Portfolio holdings
AUM
$368M
1-Year Est. Return
7.83%
This Fund
S&P 500
This Quarter
Est. Return
-0.16%
1 Year Est. Return
-7.83%
3 Year Est. Return
+16.04%
5 Year Est. Return
+24.66%
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$6.51M
(+2.3%)
Cap. Flow
+$9.12M
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
36.27%
Holding
66
New
5
Increased
42
Reduced
15
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NE
Noble Corporation
NE
|
+$6.33M |
| 2 |
NetApp
NTAP
|
+$5.81M |
| 3 |
Becton Dickinson
BDX
|
+$5.77M |
| 4 |
BSCJ
Invesco BulletShares 2019 Corporate Bond ETF
BSCJ
|
+$890K |
| 5 |
BSCF
CLAYMORE GUGGENHEIM BULLETSHARES 2015 CORP BD ETF
BSCF
|
+$837K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$6.26M |
| 2 |
Medtronic
MDT
|
+$5.73M |
| 3 |
Phillips 66
PSX
|
+$4.95M |
| 4 |
United Therapeutics
UTHR
|
+$1.53M |
| 5 |
Xerox
XRX
|
+$261K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.75% |
| 2 | Industrials | 8.81% |
| 3 | Healthcare | 8.5% |
| 4 | Financials | 7.53% |
| 5 | Consumer Staples | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
51
DELISTED
Select Medical
SEM
| $1.89M | 0.64% |
292,212
+48,506
| +20% | +$375K |
|
52
Vanguard Total Stock Market ETF
VTI
$654B
| $821K | 0.28% |
8,107
-858
| -10% | -$87.7K |
|
53
iShares Silver Trust
SLV
$28.1B
| $690K | 0.23% |
42,228
+3,669
| +10% | +$69.4K |
|
54
Vanguard Total International Stock ETF
VXUS
$153B
| $551K | 0.19% |
10,799
-1,116
| -9% | -$59.8K |
|
55
3M
MMM
$89B
| $495K | 0.17% |
4,176
+15
| +0.4% | +$1.8K |
|
56
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $475K | 0.16% |
20,471
+624
| +3% | +$15.6K |
|
57
Johnson & Johnson
JNJ
$634B
| $419K | 0.14% |
3,932
+5
| +0.1% | +$519 |
|
|
GRMN
58
Garmin
GRMN
$46.9B
| $348K | 0.12% |
6,700
| – | – |
|
59
GE Aerospace
GE
$367B
| $291K | 0.1% |
2,370
+6
| +0.3% | +$748 |
|
60
Coca-Cola
KO
$354B
| $260K | 0.09% |
6,097
-110
| -2% | -$4.55K |
|
61
AT&T
T
$165B
| $259K | 0.09% |
9,733
+74
| +0.8% | +$1.97K |
|
62
Gilead Sciences
GILD
$161B
| $236K | 0.08% |
+2,215
| New | +$217K |
|
63
Berkshire Hathaway Class A
BRK.A
$1.07T
| $207K | 0.07% |
+1
| New | +$200K |
|
|
64
Intel
INTC
$464B
| – | – |
-202,739
| Closed | -$6.26M |
|
|
65
Medtronic
MDT
$107B
| – | – |
-89,854
| Closed | -$5.73M |
|
|
66
Phillips 66
PSX
$82.9B
| – | – |
-61,538
| Closed | -$4.95M |
|
Similar funds
NCMW
GCP
PC
CLM
SFM
OTC
BTNA
FIMG
Evanston Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, Evanston Advisors held 66 positions worth $295M, up 2.3% from $289M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Evanston Advisors deployed $9.12M of net new capital in Q3 2014, opening 5 new positions and adding to 42 existing holdings. Its largest new stake was Noble Corporation: 234,748 shares worth $5.22M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was United Therapeutics, an estimated $1.53M trimmed.
- Evanston Advisors's largest Q3 2014 buy was Noble Corporation: 234,748 shares worth $5.22M.
- Evanston Advisors added most to Invesco BulletShares 2019 Corporate Bond ETF in Q3 2014, an estimated $890K increase.
- Evanston Advisors's biggest Q3 2014 reduction was United Therapeutics, cutting an estimated $1.53M.
- Evanston Advisors fully exited Intel in Q3 2014, selling an estimated $6.26M.
- Evanston Advisors's ten largest holdings make up 36% of its $295M portfolio in Q3 2014.
- Evanston Advisors opened 5 new positions and closed 3 in Q3 2014.
- Evanston Advisors's portfolio value rose 2.3% quarter-over-quarter to $295M.
Based on Evanston Advisors's 13F filing for Q3 2014, filed 15 Oct 2014.